Avidity Biosciences
148 hedge funds and large institutions have $1.57B invested in Avidity Biosciences in 2022 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 75 increasing their positions, 21 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
17% more funds holding
Funds holding: 127 → 148 (+21)
5.3% more ownership
Funds ownership: 102.46% → 107.76% (+5.3%)
44% less call options, than puts
Call options by funds: $3.1M | Put options by funds: $5.51M
Holders
148
Holding in Top 10
4
Calls
$3.1M
Puts
$5.51M
Top Buyers
| 1 | +$72.9M | |
| 2 | +$40.2M | |
| 3 | +$34.1M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$32.2M |
| 5 |
BlackRock
New York
|
+$25.8M |
Top Sellers
| 1 | -$52.8M | |
| 2 | -$47.3M | |
| 3 | -$4.42M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$2.54M |
| 5 |
ACM
Altium Capital Management
New York
|
-$2.45M |